Immunization with Recombinant Pneumolysin Induces the Production of Antibodies and Protects Mice in a Model of Systemic Infection Caused by Streptococcus pneumoniae
Authors:
- 1 February 2020
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 168 (4) , 485-487
Abstract
Immunogenic and protective activity of recombinant pneumolysin was studied in experiments on male BALB/c mice. The mice were immunized intraperitoneally with recombinant pneumolysin sorbed on Al(OH)3 (200 μg per mouse). In 2 weeks after immunization, the isotypes of antibodies to recombinant pneumolysin in the serum of immunized mice were determined by ELISA. The animals were infected with Streptococcus pneumoniae serotype 3. Immunization with recombinant pneumolysin induced the production of anti-pneumolysin antibodies, mainly of IgG1 subisotype. On day 21 after intraperitoneal infection with S. pneumoniae serotype 3 in a dose of 106 microbial cells, the survival rate of animals immunized with recombinant pneumolysin in a dose of 25 μg/mouse was 67% vs. 0% in the control (pS. pneumoniae.Keywords
This publication has 6 references indexed in Scilit:
- Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countriesBMC Infectious Diseases, 2018
- Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired PneumoniaInternational Journal of Molecular Sciences, 2018
- Streptococcus pneumoniae: transmission, colonization and invasionNature Reviews Microbiology, 2018
- Pneumococcal conjugate vaccine use in adults – Addressing an unmet medical need for non-bacteremic pneumococcal pneumoniaVaccine, 2017
- Rationale and prospects for novel pneumococcal vaccinesHuman Vaccines & Immunotherapeutics, 2015
- Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for ProtectionClinical Infectious Diseases, 2008